Sorry, I'm probably boring you all to tears with so much posting, but buying this minicircle technology just might be the best decision BLT ever made.
This is a news article on minicircles that makes it easier to understand and isn't as gruelling as reading a research report. Looks like this tech might replace the AAVs as the delivery vehicle of choice. That would be fine by me.
http://news.stanford.edu/news/2010/february1/longaker-stem-cells-020710.html
This next research report doesn't actually mention RNAi, but the comment at the end regarding minicircles is interesting:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892897/
"With its basic molecular principles and straightforward protocol, minicircle DNA is ideally suited for facilitating iPS cell research around the world. Finally, the minicircle DNA is already FDA approved, giving our novel method the potential for significant clinical translation."
- Forums
- ASX - By Stock
- BLT
- in-vivo non-viral delivery of shrna for mi
in-vivo non-viral delivery of shrna for mi, page-12
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online